OCGN Kirsten Castillo buys $23K worth of shares
Nov 27, 2024, 5:31 AM
-26.87%
What does OCGN do
Ocugen is a biopharmaceutical company based in Malvern, Pennsylvania, focused on gene and cell therapies for eye diseases, including inherited retinal disorders. The company also develops inhalation-based vaccines for COVID-19 and seasonal flu.
Kirsten Castillo bought 25,000 shares of OCGN on 22 November at $0.91 per share, worth a total of $23K. They now own 75,000 OCGN shares, or a 50% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.